Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 26Lymphoma, Large B-Cell, Diffuse 9Lymphoma, Follicular 8Lymphoma 6Lymphoma, Non-Hodgkin 5Leukemia, Lymphocytic, Chronic, B-Cell 4Neoplasms 3Lymphoma, B-Cell, Marginal Zone 3Recurrence 2Myelodysplastic Syndromes 2Leukemia, Myelomonocytic, Chronic 2Burkitt Lymphoma 2Smoldering Multiple Myeloma 1Neoplasms, Plasma Cell 1Lymphoma, Mantle-Cell 1Lymphoma, B-Cell 1Leukemia, Plasma Cell 1Leukemia, Hairy Cell 1Leukemia 1Hodgkin Disease 1Hematologic Diseases 1GATA2 Deficiency 1Dendritic Cell Sarcoma, Interdigitating 1Carcinoma, Hepatocellular 1Anemia, Refractory, with Excess of Blasts 1Anemia 1

Interventions

Dexamethasone 2Bortezomib 2pomalidomide 1isatuximab 1fludarabine phosphate 1elotuzumab 1carfilzomib 1belantamab mafodotin 1Whole-Body Irradiation 1Tacrolimus 1Sirolimus 1Peripheral Blood Stem Cell Transplantation 1Patient Reported Outcome Measures 1Mycophenolic Acid 1Methotrexate 1Melphalan 1Lenalidomide 1Fecal Microbiota Transplantation 1Etoposide 1Cyclosporine 1Cyclophosphamide 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Plasma Cell × Lenalidomide × 30 days × Clear all
NCT07600151 2026-05-20

CONQUISTADOR

Universitätsklinikum Hamburg-Eppendorf

Phase 1/2 Not yet recruiting
220 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡